Estimation of expectedness: Predictive accuracy of standard therapy outcomes in randomized phase 3 studies in epithelial ovarian cancer

By Castonguay Vincent   Wilson Michelle K.   Diaz-Padilla Ivan   Wang Lisa   Oza Amit M.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 413-422

Blackwell Publishing

Access to resources Recommend Favorite

From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer

By Góómez-Raposo Céésar   Mendiola Marta   Barriuso Jorge   Hardisson David   Redondo Andréés  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 591-594

Informa Healthcare

Access to resources Recommend Favorite

Targeted therapy for epithelial ovarian cancer

By Sharma Sameer   Odunsi Kunle  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 501-513

Informa Healthcare

Access to resources Recommend Favorite

The potential of sunitinib as a therapy in ovarian cancer

By Leone Roberti Maggiore Umberto   Valenzano Menada Mario   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1671-1686

Informa Healthcare

Access to resources Recommend Favorite

Biomarkers for Systemic Therapy in Ovarian Cancer

By  

Current Cancer Drug Targets, Vol. 14, Iss. 3, 2014-03 ,pp. : 259-273

Bentham Science Publishers

Access to resources Recommend Favorite